Presentation NY Valves 2024 Patient Selection in Transcatheter Tricuspid Valve Replacement: How to Best Use Multimodality Imaging? Presenter: Anna Sannino June 05, 2024
Presentation NY Valves 2024 Immediate and Early Results of Bicaval Valve Implantation - TricValve - A Case Series Presenter: Mohamad Said Ghandour June 05, 2024
Presentation NY Valves 2024 What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly Presenter: Azeem Latib June 05, 2024
Presentation NY Valves 2024 Quantitation of Tricuspid Regurgitation by Cardiac Magnetic Resonance Presenter: Davide Margonato June 05, 2024
Presentation NY Valves 2024 Strategies to Improve T-TEER Imaging Guidance and Procedural Flow Presenter: Fabien Praz June 05, 2024
Presentation NY Valves 2024 Exploring the Immediate Effects of Tricuspid Transcatheter Edge-to-Edge Repair on Biventricular Cardiomechanics Presenter: Antoon van den Enden June 05, 2024
Presentation NY Valves 2024 Assessment of T-TEER Results and Intra-Procedural Outcomes Presenter: William A. Gray June 05, 2024
Presentation NY Valves 2024 Impact of Tricuspid Transcatheter Edge to Edge Repair on Right Ventricular Function Presenter: Parasuram Krishnamoorthy June 05, 2024
Presentation NY Valves 2024 Diagnostic Imaging and Preparation for T-TEER Presenter: Christian Besler June 05, 2024
Presentation NY Valves 2024 Transcatheter Aortic Valve Replacement Reduces Tricuspid Regurgitation Severity at 30 Days – Insights From a Large Academic Medical Center Study Presenter: Shreeya Shabari June 05, 2024
Presentation NY Valves 2024 Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement Presenter: Melissa Yen Yen Moey June 05, 2024
Presentation NY Valves 2024 Experience-Based Lessons Learned from Real World T-TEER Cases Presenter: Jörg Hausleiter June 05, 2024
News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
News Daily News STS Releases New Risk-Prediction Tools for Emerging Surgical Scenarios Yael L. Maxwell May 01, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease Michael O'Riordan March 20, 2024